216762 Seminar

The Drug Discovery Process in the Pharmaceutical Industry - From target to hit identification

Roman Hillig, Holger Steuber

Information for students

Die Teile (I im SS und II im WS) können in beliebiger Reihenfolge besucht werden, sie sind nicht aufbauend.

Additional information / Pre-requisites

Seminars 216761 and 216762 can be attended in arbitrary sequence, they do not build-up on each other.

Comments

Content:
1. Target Identification and Hit Finding
2. X-ray Crystallography in DD
3. Molecular Modeling
4. Fragment-Based Drug Design
5. New Modalities, New target Classes
6. Target Class: Ras GTPase superfamily
7. Target Class: Epigenetic Targets
8. Nuclear Magnetic Resonance

Dr. R. Hillig: roman.hillig@nuvisan.com
Dr. H. Steuber: holger.steuber@ nuvisan.com close

Subjects A - Z